Adam Laponis

Adam Laponis, listed as finance chief, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Twist Bioscience Corp and Eargo, Inc. In total, 42 filings cover trades dated from 17 May 2021 to 9 October 2026.

The open-market record consists of 30 sales worth €4.5M, with no purchase. Outside the open market, there are 8 share grants and 1 option exercise. 2026 to date brings no purchases and 11 sales.

The record was last updated on 13 October 2026 with an open-market sale (€343k) in Twist Bioscience Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.